Related Experiment Video
Updated: Jun 18, 2026

Evaluation of the Cognitive Performance of Hypertensive Patients with Silent Cerebrovascular Lesions
Published on: April 23, 2021
Hypertension and dementia
Michiaki Nagai1, Satoshi Hoshide, Kazuomi Kario
1Division of Cardiovascular Medicine, Department of Medicine, Jichi Medical University School of Medicine, Tochigi, Japan.
Insights
Hypertension is a significant risk factor for cognitive decline, including Alzheimer's disease and vascular dementia. Managing blood pressure may help prevent dementia and cognitive impairment.
Area of Science:
- Neurology
- Cardiovascular Medicine
- Gerontology
Background:
- Hypertension is a known cause of vascular dementia (VaD).
- Emerging evidence links hypertension to Alzheimer's disease (AD) and mild cognitive impairment (MCI) pathogenesis.
- Disrupted diurnal blood pressure (BP) variation correlates with cognitive impairment, potentially through small cerebral artery damage.
Purpose of the Study:
- To review the role of hypertension as a risk factor for cognitive impairment.
- To summarize current knowledge on ambulatory BP monitoring (ABPM) and cognitive impairment.
- To provide an overview of antihypertensive therapy's impact on dementia prevention.
Main Methods:
- Literature review of studies on hypertension, cognitive impairment, and dementia.
- Analysis of findings relating ambulatory BP monitoring to cognitive function.
- Synthesis of evidence from clinical trials on antihypertensive therapy and cognitive outcomes.
Main Results:
- Long-standing hypertension is associated with brain atrophy and white matter lesions (WMLs).
- BP-lowering treatments have shown potential in reducing dementia risk and cognitive decline.
- ABPM provides insights into BP variations linked to cognitive impairment.
Conclusions:
- Hypertension is a critical modifiable risk factor for various forms of cognitive impairment and dementia.
- Ambulatory BP monitoring is valuable for assessing BP-related cognitive risks.
- Antihypertensive therapy may play a crucial role in dementia prevention strategies.
Abstract:
Although hypertension is well known as a cause of vascular dementia (VaD), recent findings highlight the role of hypertension in the pathogenesis of Alzheimer's disease (AD) as well as mild cognitive impairment (MCI). Recent studies have shown that disruption of diurnal blood pressure (BP) variation is closely associated with cognitive impairment via injury of the small cerebral arteries indicating that long-standing hypertension constitutes a risk of brain matter atrophy or white matter lesions (WMLs). In several clinical trials, BP-lowering with antihypertensive agents was suggested to reduce the risk of dementia or cognitive decline. This review paper focuses on the role of hypertension as a risk factor for cognitive impairment, and summarizes current knowledge on the relationships between ambulatory BP monitoring (ABPM) and cognitive impairment. Finally, an overview of the impact of antihypertensive therapy on dementia prevention is provided.
More Related Videos
Related Concept Videos
Dementia l: Introduction
Dementia
The progression of dementia is generally gradual.
Hypertension and Regulation of Blood Pressure
Hypertension III: Clinical Manifestations and Diagnostic Studies
Hypertension V: Nursing Management
Hypertension I: Introduction
